Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA (vonoprazan) Tablets through May 3, 2032
FLORHAM PARK, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc.…
NWTN Investors Have Opportunity to Join NWTN Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm,…
OHI Group S.A. Announces Consent Solicitation Relating to its U.S.$400,000,000 13.000% Senior Secured Amortizing Notes due 2029 Regulation S Notes: CUSIP L7S61M AB5, ISIN USL7S61MAB59 Rule 144A Notes: CUSIP 67712M AB5, ISIN US67712MAB54 (the “Notes”)
Executive Summary — As previously announced, OHI Group S.A. (the "Issuer") is preparing…
Deckers Brands to Present at Upcoming Conferences
GOLETA, Calif.--(BUSINESS WIRE)--Deckers Brands (NYSE:DECK), a global leader in designing, marketing and…